Stock CLSR.B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Clinical Laserthermia Systems AB Swiss Exchange

Equities

CLSR.B

SE0002756130

End-of-day quote Swiss Exchange
Other stock markets
- SEK - Intraday chart for Clinical Laserthermia Systems AB
Apr. 30 Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory MT
Apr. 11 Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System
CI
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories
CI
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy
CI
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System
CI
Clinical Laserthermia Systems AB Announces Publication of Preclinical Assessment of A Non-Cooled MR Thermometry-Based Neurosurgical Laser Therapy System
CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Clinical Laserthermia Systems Files Patent Extension, Expansion for Non-cooled Laser Applicators
MT
Clinical Laserthermia Systems AB Files A New Patent Application for Expanded and Extended Protection of the Company's Technology for Laser-Based Tissue Ablation Until 2044
CI
Clinical Laserthermia Systems AB Future-Proofs its Core Technology for MRI-Guided Laser Ablation in A New Agreement with Image Guided Therapy SA
CI
Clinical Laserthermia Systems Obtains Marketing Approval for Tranberg Thermal Therapy Portfolio in Singapore
MT
Clinical Laserthermia Systems AB Receives Market Approval for Its TRANBERG Portfolio by HSA in Singapore and Initiates the Process of Commercialization in the Region
CI
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise
MT
Clinical Laserthermia Systems Receives SEK 8.1 Million Order from Clearpoint Neuro
CI
Clinical Laserthermia Systems AB Announces First Patient was Safely Treated with CLS TRANBERG® Thermal Therapy system for laser ablation of Prostate Cancer
CI
Clinical Laserthermia Systems AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Clinical Laserthermia Partners with Avanco Advanced Medical Solutions for Tranberg Sale in Portugal
MT
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with Avanco Advanced Medical Solutions
CI
Clinical Laserthermia Systems, Halo Diagnostics to Conduct Prostate Cancer Clinical Trial
MT
Clinical Laserthermia Systems Announces Initiation of Prostate Cancer Clinical Study in Collaboration with U.S Based Halo Diagnostics
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. CLSR.B Stock
  5. News Clinical Laserthermia Systems AB
  6. Highlights